- Interrogating bioinspired ESIPT/PCET-based Ir(iii)-complexes as organelle-targeted phototherapeutics: a redox-catalysis under hypoxia to evoke synergistic ferroptosis/apoptosis
Maniklal Shee et al, 2023, Chemical Science CrossRef - Synthesis of Pharmacologically Potent Benzimidazole Analogs
Jeelan Basha Nagenahalli et al, 2024, Polycyclic Aromatic Compounds CrossRef - Bendamustine as a Cause of Drug-Associated Bullous Pemphigoid—A Rare Side Effect
Preema Sinha et al, 2024, Indian Dermatology Online Journal CrossRef - Design, Synthesis, Antitumor, and Antiplasmodial Evaluation of New 7-Chloroquinoline–Benzimidazole Hybrids
Luka Krstulović et al, 2024, Molecules CrossRef - Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking
Luka Krstulović et al, 2023, Molecules CrossRef - LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair
Jianli Zhou et al, 2023, Oncotarget CrossRef - Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine
Jen-Pei Huang et al, 2024, Annals of Hematology CrossRef - Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases
Igor Aurer et al, 2024, Biomedicines CrossRef - Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
Dan Li et al, 2024, Frontiers in Pharmacology CrossRef - Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence
Apoorv Kirti et al, 2024, Cancer Letters CrossRef - Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study
Jung Ah Lee et al, 2024, Journal of Korean Medical Science CrossRef - Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?
Dimitrios Filioglou et al, 2023, Frontiers in Immunology CrossRef - Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives
Bruno Almeida Costa et al, 2023, Critical Reviews in Oncology/Hematology CrossRef - Novel Fluorescent Benzimidazole-Hydrazone-Loaded Micellar Carriers for Controlled Release: Impact on Cell Toxicity, Nuclear and Microtubule Alterations in Breast Cancer Cells
Rayna Bryaskova et al, 2023, Pharmaceutics CrossRef - Organic Nanomaterials Loaded with Cytotoxic Agents: A Therapeutic Alternative Against Cancer
Jorge L. Mejía-Méndez et al, 2024, null CrossRef - Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy
Yutaka Shimazu et al, 2023, Annals of Hematology CrossRef - Synthesis and Biochemical Evaluation of Ethanoanthracenes and Related Compounds: Antiproliferative and Pro-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL)
James P. McKeown et al, 2024, Pharmaceuticals CrossRef - Advancements in the impact of human microbiota and probiotics on leukemia
Yi Zhang et al, 2024, Frontiers in Microbiology CrossRef - Benzimidazole‐Containing Compounds as Anticancer Agents
Ulviye Acar Çevik et al, 2024, ChemistrySelect CrossRef - Can pharmacy students use Wikipedia as a learning resource? Critical assessment of articles on chemotherapeutic drugs
Samy A. Azer et al, 2023, Advances in Physiology Education CrossRef - Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
Davor Galusic et al, 2022, HemaSphere CrossRef - Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy
Celia María Curieses Andrés et al, 2024, Cancers CrossRef